Bipolar Disorder Type Ii clinical trials

Explore recruiting bipolar disorder type ii clinical trials.

Recruiting bipolar disorder type ii studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Bipolar Disorder Type Ii trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Lithium versus Lamotrigine in bipolar disorder, type II – a single blinded randomized controlled trial (the LiLa-Bipolar RCT)

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

Bipolar Disorder Type Ii trials by city

Bipolar Disorder Type Ii in Toronto Bipolar Disorder Type Ii in Vancouver Bipolar Disorder Type Ii in Montreal Bipolar Disorder Type Ii in Calgary Bipolar Disorder Type Ii in Edmonton Bipolar Disorder Type Ii in Ottawa Bipolar Disorder Type Ii in Winnipeg Bipolar Disorder Type Ii in Quebec City Bipolar Disorder Type Ii in Hamilton Bipolar Disorder Type Ii in Kitchener Bipolar Disorder Type Ii in London Bipolar Disorder Type Ii in Halifax Bipolar Disorder Type Ii in New York Bipolar Disorder Type Ii in Los Angeles Bipolar Disorder Type Ii in Chicago Bipolar Disorder Type Ii in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease